Travelers Vaccines Market Rides High on Increasing Leisure Travel to Overseas Destinations

According to a new business intelligence publication by Transparency Market Research, the global travelers vaccines market is predicted to expand at a healthy clip over the 2017-2025 forecast timeframe. The report, titled “Travelers Vaccines Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025,” presents an in-depth analysis of demand drivers, challenges, and opportunities that will influence the said market over the forecast period of 2017-2025. Included in the report is a comprehensive analysis of key market segments under different categories, which includes market share projections of these segments over the aforementioned forecast period.

The report serves as a decision making tool for its target audiences, which includes pharmaceutical companies, academic research institutes, medical research laboratories, research and development organizations, and hospitals and clinics.

The report studies the traveler’s vaccines market on the basis of type of composition, type of use, and geography. On the basis of composition, the market for traveler’s vaccines could be bifurcated into combination vaccines and mono vaccines. Of the two, the combination vaccines segment is rising at a rapid pace as they require fewer injections for treating multiple diseases.

On the basis of type of use, traveler’s vaccines market could be bifurcated into attenuated vaccines, subunit vaccines, conjugate vaccines, recombinant vector vaccines, inactive vaccines, toxoid vaccines, and DNA vaccines.

Powered by the U.S., North America is likely to hold dominance in the traveler’s vaccines market over the report’s forecast period. Europe is a significant market for traveler’s vaccines due to increasing expenditure on research and development and high awareness among individuals to follow region-specific immunization plan before travelling to disease prone regions. Asia Pacific is emerging as a key market for traveler’s vaccines due to development of healthcare facilities.

Key players in the traveler’s vaccines market include GlaxoSmithKline plc, Pfizer Inc., Merck & Co., and Sanofi S.A.

Get Report Brochure @

Leave a Reply